Legal status · Canada
Is ABT-737 legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. ABT-737 is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
ABT-737 in Canada at a glance
| Classification | Not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 2 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the ABT-737 profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing ABT-737 is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What ABT-737 is
The laboratory predecessor of navitoclax, used as a senolytic tool compound in mice. No one has ever been given ABT-737 in a published clinical study; it is not orally bioavailable, which is why the orally available analogue was developed and taken into people instead.
ABT-737 is a BH3 mimetic that binds BCL-2, BCL-xL and BCL-w and triggers apoptosis in cells that depend on them. It is the parent compound of navitoclax, which the ovarian cancer investigators describe plainly as the orally available ABT-737 analogue.
Mechanism: Established in cells and in mice: ABT-737 occupies the BH3 binding groove of BCL-2, BCL-xL and BCL-w, releasing BAX and BAK and committing the cell to apoptosis. Senescent cells in mouse tissues upregulate these proteins to survive, which is the basis of the selectivity seen in animal experiments.
Regulatory history: Not approved and not in clinical development. A preclinical research compound with no registered human trial. Its oral analogue navitoclax reached phase 1 and 2 oncology trials and is also unapproved.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for ABT-737 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
ABT-737 in other countries
Frequently asked questions
Is ABT-737 legal in Canada?
No. ABT-737 is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy ABT-737 in Canada?
No approved product exists to buy. In Canada ABT-737 is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is ABT-737 Health Canada approved?
No. In Canada ABT-737 is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved and not in clinical development. A preclinical research compound with no registered human trial. Its oral analogue navitoclax reached phase 1 and 2 oncology trials and is also unapproved.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for ABT-737 live on its compound profile.
ABT-737 profileThis page is general information about the regulatory status of ABT-737 in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.